Ranbaxy Q1 net plunges 90 per cent to Rs 126 cr

Ranbaxy Laboratories has posted a 89.91 per cent decline in its consolidated net profit at Rs 125.75 crore for the first quarter ended March 31, 2013.

The company had posted a net profit of Rs 1,246.76 crore in the same period of previous year.

In a filing to the Bombay Stock Exchange, Ranbaxy Laboratories said net sales of the company declined to Rs 2,439.82 crore for the January-March quarter, compared to Rs 3,708.97 crore in the same period of 2012.

Ranbaxy shares closed 2.78 per cent down at Rs 443.80 on BSE.